Cancer Research Technology
Log in Register
Menu

Anti-ORF45 [ORF45] monoclonal antibody

Invented at Florida State University

Info

Catalogue Number 160637
Applications IP WB
Antigen/Gene or Protein Targets Open Reading Frame 45
Reactivity Other Species
Relevance Kaposi's sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi's sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015).

ORF45 (tegument) is a gene associated with the lytic viral life cycle of KSHV and has been shown to have multiple functions throughout the viral life cycle. ORF45 is a crucial component of progeny virion production in conjunction with ORF33. ORF45 binds to and stabilizes ORF33. This anti-ORF45 has been shown to purify different populations of ORF45 as well as enable the targeted depletion or enrichment of subpopulations of ORF45. This anti-ORF45 was generated using a baculovirus-synthesized ORF45 as an antigen.
Host Mouse
Immunogen A baculovirus-synthesized ORF45 protein was used as an antigen
Subclass IgG
Research Area Gene Expression, Virology

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Wu et al. 2016. J Virol. 90(4):1741-56. PMID: 26637455.

Gillen et al. 2015. J Virol. 89(9):4918-31. PMID: 25694600.


Add a reference

References: 2 entries

Wu et al. 2016. J Virol. 90(4):1741-56. PMID: 26637455.

Gillen et al. 2015. J Virol. 89(9):4918-31. PMID: 25694600.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor